prognostic markers I

Expression patterns of hyaluronan receptors CD44 and RHAMM in transitional cell carcinoma of urinary bladder

H Li MD Phd, R Qi, T Wang MD, Q-zh Guo MD PhD, J Liu MD PhD

Enhanced matrix metalloproteinase expression in cancer cells by the cleaved form of alpha-1-antitrypsin

S Janciauskiene PhD

Cancer of the tongue: the role of apoptotic vs necrotic and proliferative tumor markers as related to clinical and prognostic characteristics

RM Nagler MD MSc PhD , D Laufer MD , O Ben-Itzhak MD

The in vitro response of primary cultures of tumour material to DNA damage: comparison with that of established cell lines

BC Baguley PhD, ES Marshall NZCS

Hormone Replacement Therapy in women with a history of Breast Cancer - a case control study

M Ursic-Vrscaj MD PhD, S Bebar MD

Diverse expansion potential and heterogeneous avidity in tumor associated antigen-specific T lymphocytes from primary melanoma patients

B Palermo PhD , R Campanelli DSc , S Garbelli DSc , S Mantovani DSc , AM Manganoni MD , G Carella PhD , GA Da Prada MD , G Robustelli-della-Cuna MD , A Necker PhD , E Lantelme PhD , C Giachino PhD

Melanin pigmented oncocytic metaplasia of the nasopharynx

E Hirakawa MD , H Miki MD , M Ohmori MD , S Kobayashi MD , K Yamamoto BS

Prognostic value of DNA ploidy response to chemotherapy in human osteosarcomas

K Kusuzaki MD , H Takeshita MD , H Murata MD , S Hashiguchi MD , M Hirata MD , T Ashihara MD , Y Hirasawa MD

Connexin43 expression decreased with tumor growth in renal cancer

M Noguchi MD, K Nomata MD, S Koga MD, H Kanetake MD

KAI1, a metastasis suppressor gene: a potential prognostic marker in prostate cancer?

M Lijovic BSc, AG Frauman MD

Epidermal growth factor receptor gene amplification as a prognostic marker in glioblastoma multiforme: results of a meta-analysis

MS Huncharek MD , B Kupelnick BA

Cathepsins B, L and inhibitors stefin A and cystatin C in meningiomas

T Strojnik MD, TT Lah PhD , B Židanik MD , J Kos PhD

Alpha-L-fucosidase activity as a useful prognostic indicator in serum of colorectal cancer patients with Dukes' stages B or C Comparison with other prognostic tumor markers

D Ayude BSc, FJ Rodríguez-Berrocal PhD, M Acuña BSc, MF Montenegro BSc, VS Martínez-Zorzano PhD, A de Carlos PhD, M Páez de la Cadena PhD

Combination of DD23 and cytopathology in the detection of recurrent transitional cell carcinoma (TCC)

SM Gilbert MD , A Shabsigh MD , A Sawczuk RN , U Vasa MD , A Ng PhD , C Pickens MS , K Norris BS , S Bright BS , GJ O'Dowd MD , RW Veltri PhD , MC Benson MD , CA Olsson MD , IS Sawczuk MD

The invading front of malignant tumors is a source of prognostic information

T Goldmann PhD , L Suter MD , D Ribbert PhD , F Witt MD , A Moorkamp MD , E Vollmer MD , F Otto PhD

Use of FDP and F1P aldolase to detect tumorous and nontumorous tissue damage by ethanol injection of hepatocellular carcinoma

KN Khan MD PhD , K Nakata MD , K Nakao MD , Y Kato MD , K Eguchi MD

Tumour infiltrating macrophages, microvessels, and prognosis in malignant uveal melanoma

T Kivelä MD , T Mäkitie MD , P Summanen MD , A Tarkkanen MD

ETS-1 expression in human oral squamous cell carcinoma: Potential prognostic implications

P Pande MSc , N Chakravarti MSc , S Soni MSc , M Mathur MD , NK Shukla MS , R Ralhan PhD

Demonstration of p53 autoantibodies in sera indicates a fatal outcome in patients suffering from transitional cell carcinoma of urinary bladder

W Hindermann MD , H Wunderlich MD , U Junker MD , A Berndt MD , H Kosmehl MD

Dna content and survival rates of patients with renal cell carcinoma: a prospective study on 230 cases

H Al-Abadi MD , V Borgmann MD , I Rotter CTIAC , R Nagel MD , P Neuhaus MD

Role of Bcl-2 positivity on survival in patients with lung cancer: a meta-analysis with qualitative assessment of the literature

T Berghmans MD, B Martin PhD, M Paesmans MSc, F Branle MD, A Burniat MD, L Ghisdal MD, JJ Lafitte MD, C Mascaux MD, AP Meert MD, E Steels MD, F Vallot MD, JM Verdebout MD, JP Sculier MD